{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicyww6zp42b6tks3psw5wiaazn3xzjx3agh25gzpaalzzdvfzvsnq",
    "uri": "at://did:plc:2gbt2dlwaqovtnmxkat3tyke/app.bsky.feed.post/3mhi7fq3q7ab2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiclaoeji4xw3btpdoktbbqiwvreihdnonkuqnbxwtyu2754x52gme"
    },
    "mimeType": "image/jpeg",
    "size": 266500
  },
  "path": "/articles/d41586-026-00852-x",
  "publishedAt": "2026-03-20T09:30:52.853Z",
  "site": "https://www.nature.com",
  "tags": [
    "doi:10.1038/d41586-026-00852-x"
  ],
  "textContent": "Nature, Published online: 19 March 2026; doi:10.1038/d41586-026-00852-x\n\nMuscle mass increased or remained stable relative to body weight in middle-aged mice and humans on GLP-1 drugs.",
  "title": "Strength persists after a mid-life course of obesity drugs",
  "updatedAt": "2026-03-19T00:00:00.000Z"
}